Joel Credle
banner
sciencealwayswins.bsky.social
Joel Credle
@sciencealwayswins.bsky.social
Scientific Co-founder @ Infinity Bio & Portal Biosciences | Director of R & D | Antibody & RNA Analysis Solutions
Reposted by Joel Credle
The first authors developed an integrative model, Mal-ID.To address a gap in current diagnostic medical practices, which do not yet utilize the adaptive immune system’s B cell receptor (BCR) and T cell receptor (TCR) sequences in diagnosis.
April 2, 2025 at 3:31 PM